For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
Research Comparison
Ipamorelin and Tesamorelin both influence the growth-hormone axis but through different mechanisms. Ipamorelin is a GH secretagogue acting on GHSR-1a, whereas Tesamorelin is a stabilized GHRH (GRF 1-44) analog acting on the GHRH receptor.
| Attribute | Ipamorelin | Tesamorelin |
|---|---|---|
| Receptor target | GHSR-1a | GHRH receptor |
| Class | GH secretagogue | GHRH analog |
| Research focus | Pulsatile GH release | GH axis + lipid metabolism |
| Signaling | Short, pulsatile | GHRH-receptor mediated |
No. Tesamorelin is a GHRH analog acting on the GHRH receptor, while Ipamorelin is a secretagogue acting on GHSR-1a. The two act on different receptors of the same axis.